Trust Company’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $118K | Buy |
305
+30
| +11% | +$11.1K | 0.01% | 211 |
|
|
2026
Q1 | $80.5K | Buy |
275
+25
| +10% | +$8.22K | 0.01% | 249 |
|
|
2025
Q4 | $87.6K | Sell |
250
-2
| -0.8% | -$676 | 0.01% | 238 |
|
|
2025
Q3 | $81.4K | Hold |
252
| – | – | 0.01% | 187 |
|
|
2025
Q2 | $98K | Hold |
252
| – | – | 0.01% | 180 |
|
|
2025
Q1 | $110K | Buy |
252
+2
| +0.8% | +$803 | 0.01% | 169 |
|
|
2024
Q4 | $92.2K | Buy |
+250
| New | +$105K | 0.01% | 184 |
|
|
2021
Q4 | – | Sell |
-333
| Closed | -$124K | – | 322 |
|
|
2021
Q3 | $124K | Hold |
333
| – | – | 0.03% | 132 |
|
|
2021
Q2 | $127K | Hold |
333
| – | – | 0.09% | 121 |
|
|
2021
Q1 | $120K | Sell |
333
-167
| -33% | -$53.7K | 0.09% | 130 |
|
|
2020
Q4 | $161K | Hold |
500
| – | – | 0.13% | 110 |
|
|
2020
Q3 | $134K | Hold |
500
| – | – | 0.11% | 120 |
|
|
2020
Q2 | $131K | Hold |
500
| – | – | 0.12% | 111 |
|
|
2020
Q1 | $114K | Hold |
500
| – | – | 0.13% | 101 |
|
|
2019
Q4 | $151K | Hold |
500
| – | – | 0.13% | 100 |
|
|
2019
Q3 | $120K | Hold |
500
| – | – | 0.11% | 103 |
|
|
2019
Q2 | $141K | Hold |
500
| – | – | 0.13% | 98 |
|
|
2019
Q1 | $143K | Hold |
500
| – | – | 0.08% | 105 |
|
|
2018
Q4 | $131K | Hold |
500
| – | – | 0.07% | 93 |
|
|
2018
Q3 | $137K | Hold |
500
| – | – | 0.06% | 93 |
|
|
2018
Q2 | $119K | Hold |
500
| – | – | 0.05% | 106 |
|
|
2018
Q1 | $110K | Hold |
500
| – | – | 0.04% | 112 |
|
|
2017
Q4 | $113K | Buy |
+500
| New | +$106K | 0.05% | 106 |
|
|
2017
Q2 | – | Sell |
-23
| Closed | -$4K | – | 332 |
|
|
2017
Q1 | $4K | Hold |
23
| – | – | ﹤0.01% | 319 |
|
|
2016
Q4 | $3K | Hold |
23
| – | – | ﹤0.01% | 337 |
|
|
2016
Q3 | $3K | Hold |
23
| – | – | ﹤0.01% | 364 |
|
|
2016
Q2 | $3K | Hold |
23
| – | – | ﹤0.01% | 333 |
|
|
2016
Q1 | $3K | Sell |
23
-152
| -87% | -$20.3K | ﹤0.01% | 325 |
|
|
2015
Q4 | $24.4K | Sell |
175
-67
| -28% | -$9.23K | 0.01% | 216 |
|
|
2015
Q3 | $34K | Sell |
242
-13,208
| -98% | -$1.98M | 0.02% | 202 |
|
|
2015
Q2 | $2.21M | Buy |
13,450
+1,089
| +9% | +$174K | 1.38% | 16 |
|
|
2015
Q1 | $1.91M | Buy |
+12,361
| New | +$1.76M | 1.21% | 31 |
|
Other funds holding ELV
Trust Company's ELV Position: Q2 2026 in Review
Trust Company increased its Elevance Health (ELV) stake by 11% in Q2 2026, buying an estimated $11.1K and bringing the position to 305 shares worth $118K. The position accounts for 0.01% of the portfolio, ranked #211.
Trust Company first reported a position in ELV in Q1 2015 and has held it in 32 quarters since. The position peaked at $2.21M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Trust Company held 305 shares of Elevance Health worth $118K as of Q2 2026.
- Trust Company bought 30 Elevance Health shares in Q2 2026, an estimated $11.1K.
- Elevance Health made up 0.01% of Trust Company's portfolio in Q2 2026, its #211 holding.
- Trust Company first reported a position in Elevance Health in Q1 2015 and has held it in 32 quarters since.
- Trust Company's Elevance Health position peaked at $2.21M in Q2 2015.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.